Nephrology Now retweeted
FLOW adds semaglutide as another therapy that meaningfully slows progression of CKD, while also lowering mortality, in patients with diabetes and proteinuric CKD
Presented at #ERA24:
FLOW trial: In patients with type 2 diabetes and chronic kidney disease, weekly semaglutide significantly reduced risks of major kidney events, cardiovascular events, and death from any cause while slowing loss of kidney function. nej.md/44U3slP
Nephrology Now retweeted
🔟ways #hospitalists can improve #CKD care
#SHMConverge23 #Nephrology #NephMadness @ISMMSKidney @SocietyHospMed
Nephrology Now retweeted
New educational resource: Hallway Huddle - Chronic kidney disease in type 2 diabetes by @UKidney
Speakers include @LouiseMoist1 @NavTangri @DrNguiHCF ukidney.com/nephrology-prese…
Great thread on @BEST_CLI study which included 11% patients on dialysis
Replying to @drdschwartzmd
Is @BEST_CLI relevant in patients with kidney disease or dialysis?
11% of pts on dialysis!
Cohort 1, subgroup analysis on dialysis vs not (small numbers) did not show benefit
Stop you applying result to dialysis pts? @Ask_Renal @kidney_boy @hswapnil @NephJC @VascularSVS
596
Nephrology Now retweeted
Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia from @NEJM by @BEST_CLI
- critically important study given the burden of peripheral vascular disease (>200 million globally)
What did the study find?
1/x
nejm.org/doi/full/10.1056/NE…
Nephrology Now retweeted
Chlorthalidone did not lead to a lower incidence of major cardiovascular outcomes or non–cancer-related deaths than hydrochlorothiazide
@NEJM
Nephrology Now retweeted
Insights to Guide Early Recognition and Linkage to Care in AL Amyloidosis
with @UBCmedicine faculty
Produced by @PeerVoice ca.peervoice.com/240200965/2…
Nephrology Now retweeted
Such an important paper to discuss & share
Too often we see emotional response to slowly declining GFR leading discontinuation of ACEi/ARB
We need to remind colleagues - declining GFR happens despite the standard of care. Without treatment, pts would just get worse even faster
Keep Calm and Carry on Inhibiting the RAS nephjc.com/news/stopacei
Nephrology Now retweeted
7 most impactful clinical trials focussed on slowing progression of chronic kidney disease
A Thread 🧵
A highly subjective list, but these trials have been included as they have had a meaningful impact on guidelines, patients and clinicians at a global scale.
Nephrology Now retweeted
7 ways the EMPA-KIDNEY trial will impact clinical care in CKD
A Thread 🧵
Sources @NEJM @NephJC @DiabetesCanada @AmDiabetesAssn @goKDIGO @ESC_Journals @hswapnil @kidney_boy
>80% ready to offer triple therapy with ACEi/ARB, SGLTi & Finerenone in patients with T2D, CKD and persistent proteinuria
Replying to @drdschwartzmd
Would you add finerenone to patients w/ diabetes, CKD and persistent proteinuria ( w/ normal K+) despite RAASi & SGLT2i & lifestyle changes (ie offer triple therapy)?
83%Yes
8%No
10%See comment
183 votes • Final results Nephrology Now retweeted
7 Practical Tips for Starting an SGLT2 Inhibitor
A Thread 🧵
SGLT2i inhibitors (eg empagliflozin, dapagliflozin, canagliflozin) have a phenomenal evidence base and have been shown to be beneficial in diabetes, heart disease (particularly heart failure) and kidney disease. 1/x
Nephrology Now retweeted
Should patients w/ diabetes, CKD and proteinuria despite RAASi & SGLT2i be considered for add-on therapy with finerenone (triple therapy)?
A thread 🧵 & survey (see end)
Sources
@NEJM @NephJC @goKDIGO @ESC_Journals @CADTH_ACMTS
Minimizing the risk of COVID-19 among patients on dialysis.
qxmd.com/r/32249840
Nephrology Now retweeted
If you are a healthcare worker or #firstresponder, watch this 20 second video. And know they are cheering for you.
youtu.be/va7PF9eE-tw
You have the whole world behind you.
#HealthcareHeroes #Cheer4HealthWorkers #WeApplaud
Does IV Contrast Cause AKI in Critically Ill Patients? — JournalFeed journalfeed.org/article-a-da…
5
Nephrology Now retweeted
A web-based app was developed to calculate the risk of primary endpoints in patients with newly diagnosed IgA nephropathy. The app can be found at @QxMD or here: qxmd.com/calculate/calculato… #NephJC
Papers worth reading in Nephrology
Most popular Nephrology papers for 2018 on the @QxMD platform
Have you read them all?
#nephjc #readbyqxmd #ckd #aki #acidosis #transplant
qxmd.com/r/shared-collection…
Nephrology Now retweeted
Use this predictive model in CKD prognosis on Calculate by @QxMD
qxmd.com/calculate/calculato…
Great article: Derivation and validation of a prognostic model to predict mortality in patients with adva... QxMD.com/r/30395311 #ReadByQxMD
Nephrology Now retweeted
Get the ADPKD risk calculator on your mobile device via Calculate by QxMD qxmd.com/calculate/calculato… – at New Westminster, British Columbia
Loving the ADPKD risk calculator powered by @qxmd. Includes a handy graph to automatically plot a patient’s estimated risk: ukidney.com/nephrology-res… teapawt.net/UKidney/status/1027210…

















